ReP USP - Resultado da busca

Filtros : "Frontiers Pharmacology" Limpar

Filtros

USP affiliated authors
- hirata, mario hiroyuki (~1)
- hirata, rosario dominguez crespo (~1)
- ulrich, alexander henning (~1)
Date published
- 2024 (~1)
- 2017 (~1)
Subjects
- agentes hepatotóxicos (~1)
- doenças do sistema nervoso (~1)
- micrornas (~1)
- sistema nervoso central (~1)
Language
- inglês (~2)
Source title
- frontiers pharmacology (~2)
Publisher
Conference titles
Countries/Territories
- suiça (~2)
Grupo de pesquisa
- fcf002 (~1)
- iq005 (~1)
Funding Agencies
- financiamento innovation team and talents cultivation program of the national administration of traditional chinese medicine (1)
- financiamento nsfc (1)
- financiamento sichuan provincial administration of traditional chinese medicine (1)
- financiamento sichuan science and technology program (1)
- fundação de amparo à pesquisa do estado de são paulo (fapesp) (1)

Artigo de periodico-carta/editorial
Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] (2024)
Tang, Yong ; Rubini, Patrizia; Sperlagh, Beata; Ulrich, Henning
Source: Frontiers Pharmacology. Unidade: IQ
Subjects: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 23 maio 2024. , 2024
APA
Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
NLM
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 maio 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
Vancouver
Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 maio 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
Artigo de periodico
Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells (2017)
De Freitas, Renata Caroline Costa; Bortolin, Raul H; Lopes, Mariana B; Tamborlin, Leticia; Meneguello, Leticia; Silbiger, Vivian N; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, Augusto D; Luchessi, Andre D
Source: Frontiers Pharmacology. Unidade: FCF
Subjects: MICRORNAS, AGENTES HEPATOTÓXICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE FREITAS, Renata Caroline Costa et al. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells. Frontiers Pharmacology, v. 8, p. 1-11 art.906, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00906. Acesso em: 23 maio 2024.
APA
De Freitas, R. C. C., Bortolin, R. H., Lopes, M. B., Tamborlin, L., Meneguello, L., Silbiger, V. N., et al. (2017). Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells. Frontiers Pharmacology, 8, 1-11 art.906. doi:10.3389/fphar.2017.00906
NLM
De Freitas RCC, Bortolin RH, Lopes MB, Tamborlin L, Meneguello L, Silbiger VN, Hirata RDC, Hirata MH, Luchessi AD, Luchessi AD. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells [Internet]. Frontiers Pharmacology. 2017 ; 8 1-11 art.906.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2017.00906
Vancouver
De Freitas RCC, Bortolin RH, Lopes MB, Tamborlin L, Meneguello L, Silbiger VN, Hirata RDC, Hirata MH, Luchessi AD, Luchessi AD. Modulation of miR-26a-5p and miR-15b-5p exosomal expression associated with Clopidogrel-Induced hepatotoxicity in HepG2 cells [Internet]. Frontiers Pharmacology. 2017 ; 8 1-11 art.906.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2017.00906

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024